LSVT BIG Training And Certification Course

The LSVT BIG Training and Certification Course is a two-day program designed to train physical and occupational therapy professionals and students in an evidence-based, intensive treatment protocol for individuals with Parkinson disease. The fundamental treatment principles and rationale, key treatment elements, efficacy data supporting treatment outcomes, details of treatment tasks, and practical delivery will be covered. Teaching techniques include lecture, demonstration, and case study presentations. Discussion will be included on application to other neural disorders and customization of treatment delivery to meet the unique functional goals of each patient.

Steps for Certification

• ​Register for a two-day LSVT BIG Training and Certification Course.
• Attend the entire two-day LSVT BIG Training and Certification Course.
• Complete a Certification Exam with an 85% score required to receive certification. The exam will be administered during the two-day training course. If a participant does not pass the examination, there will be an opportunity for participants to re-take the exam online.

Dr. Cynthia Fox, Ph.D., CCC‐SLP

Cynthia Fox, Ph.D., CCC-SLP received her doctorate degree in Speech and Hearing Sciences from the University of Arizona, Tucson. Her training included a focus in the areas of neuroscience and motor control. She is an expert on rehabilitation and neuroplasticity and the role of exercise in the improvement of function consequent to neural injury and disease. She has over 25 years of experience working in collaboration with expert colleagues conducting efficacy research on Lee Silverman Voice Treatment (LSVT LOUD®) in people with Parkinson’s disease (PD), as well as studying the underlying mechanisms of speech disorders in PD. Dr. Fox is a world leader in administration of LSVT LOUD speech treatment. She was the first to apply LSVT LOUD to disorders other than PD (e.g., multiple sclerosis) and pioneered the application to pediatric populations including children with cerebral palsy and Down syndrome. Dr. Fox worked closely on the development of a physical and occupational therapy program, LSVT BIG®, that was modeled after the LSVT LOUD speech treatment protocol. Dr. Fox has numerous publications in these areas of research and has presented extensively nationally and internationally. Dr. Fox is a Chief Executive Officer and Co-Founder of LSVT Global, Inc.

Cynthia Fox, Ph.D., CCC-SLP, doktora derecesini Tucson'daki Arizona Üniversitesi'nden Konuşma ve İşitme Bilimleri alanında aldı. Eğitimi, sinirbilim ve motor kontrol alanlarına odaklanmayı içeriyordu. Rehabilitasyon, nöroplastisite ve egzersizin; nöral yaralanma ve hastalığa bağlı fonksiyonların iyileştirilmesindeki rolü konusunda uzmandır. Parkinson hastalığı  olan kişilerde Lee Silverman Ses Tedavisi (LSVT LOUD)® üzerine etkinlik araştırması yapan uzman meslektaşlarıyla işbirliği içinde çalışmanın yanı sıra Parkinsonda konuşma bozukluklarının altında yatan mekanizmaları inceleyen 25 yılı aşkın deneyime sahiptir. Dr. Fox, LSVT LOUD konuşma tedavisinin yönetiminde dünya lideridir. LSVT LOUD'u Parkinson dışındaki bozukluklara (örneğin, multipl skleroz) uygulayan ilk kişi oldu ve serebral palsili ve Down sendromlu çocuklar da dahil olmak üzere pediatrik popülasyonlara uygulamaya öncülük etti. Dr. Fox, LSVT LOUD konuşma tedavisi protokolünden sonra modellenen bir fiziksel ve mesleki terapi programı olan LSVT BIG'in® geliştirilmesi üzerinde yakından çalıştı. Dr. Fox'un bu araştırma alanlarında çok sayıda yayını vardır ve ulusal ve uluslararası alanda kapsamlı sunumlar yapmıştır. Dr. Fox, LSVT Global, Inc.'in İcra Kurulu Başkanı ve Kurucu Ortağıdır.

Course Outcomes

Upon conclusion of this course, participants (Physical and Occupational Therapy Professionals and Students) will be able to:

• Describe 3 paradigm shifts unique to LSVT BIG treatment.
• Provide rationale for using a single target of amplitude when working with patients with Parkinson’s disease.
• Correctly identify at least 3 key principles used in LSVT BIG that drive activity dependent neuroplasticity.
• Discuss efficacy findings that support use of LSVT BIG for persons with Parkinson’s disease.
• Provide the rationale for each of the Maximal Daily Exercises.
• Describe the correct performance techniques of the LSVT Maximal Daily Exercises.
• Given patient scenarios of patients with Parkinson’s disease with various levels of function, describe how to adapt or progress LSVT BIG treatment.
• Correctly list 5/5 teaching techniques unique toLSVT protocols.
• Differentiate between Functional Component Tasks, Hierarchy Tasks, and Carryover tasks.
• Identify the purposes of Functional Component Tasks, Hierarchy Tasks, and Carryover Tasks.
• Provide an example of calibration in LSVT BIG.
• Synthesize data from patient interview, examination, stimulability tests and results of standardized tests to determine if the patient will benefit from LSVT BIG treatment.